A Computational Cognitive Biomarker for Early-Stage Huntington's Disease.
Huntington's disease (HD) is genetically determined but with variability in symptom onset, leading to uncertainty as to when pharmacological intervention should be initiated. Here we take a computational approach based on neurocognitive phenotyping, computational modeling, and classification, i...
Saved in:
| Main Authors: | Thomas V Wiecki, Chrystalina A Antoniades, Alexander Stevenson, Christopher Kennard, Beth Borowsky, Gail Owen, Blair Leavitt, Raymund Roos, Alexandra Durr, Sarah J Tabrizi, Michael J Frank |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2016-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0148409 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cell-specific mechanisms drive connectivity across the time course of Huntington’s disease
by: Carlos Estevez-Fraga, et al.
Published: (2025-07-01) -
Cerebrospinal Fluid Inflammatory Biomarkers Reflect Clinical Severity in Huntington's Disease.
by: Filipe Brogueira Rodrigues, et al.
Published: (2016-01-01) -
Stage-Specific Serum Proteomic Signatures Reveal Early Biomarkers and Molecular Pathways in Huntington’s Disease Progression
by: Christiana C. Christodoulou, et al.
Published: (2025-08-01) -
Mutant Huntingtin Does Not Affect the Intrinsic Phenotype of Human Huntington's Disease T Lymphocytes.
by: James R C Miller, et al.
Published: (2015-01-01) -
Decoding dynamic brain networks in Parkinson’s disease with temporal attention
by: Salil B Patel, et al.
Published: (2025-05-01)